Your Top 100 most-cited badge
A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.
The article
LBA79 GEMSTONE-303: Prespecified progression-free survival (PFS) and overall survival (OS) final analyses of a phase III study of sugemalimab plus chemotherapy vs placebo plus chemotherapy in treatment-naïve advanced gastric or gastroesophageal junction (G/GEJ) adenocarcinoma
Xiao Zhang, J. Wang, G. Wang, Yongyi Zhang, Qingxia Fan, Liao Chuang-xin and 14 more
- Rank
- 100 of 3,639
- Percentile
- top 2.8%
- Where
- Annals of Oncology, 2023
- Citations
- 30
From the 2023 list, OpenAlex counts as of 2026-10-29.
Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.